Cargando…
Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
Tumour angiogenesis, described by Folkman in the early seventies, is an essential, complex, and dynamic process necessary for the growth of all solid tumours. Among the angiogenic factors secreted by the tumour cells, the Vascular Endothelial Growth Factor (VEGF) is one of the most important. Most t...
Autores principales: | Grépin, Renaud, Pagès, Gilles |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836176/ https://www.ncbi.nlm.nih.gov/pubmed/20224655 http://dx.doi.org/10.1155/2010/835680 |
Ejemplares similares
-
Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies
por: Guyot, Mélanie, et al.
Publicado: (2016) -
Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
por: Montemagno, Christopher, et al.
Publicado: (2020) -
Mechanisms of resistance to anti-angiogenic treatments
por: Pezzella, Francesco
Publicado: (2019) -
Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas
por: Dumond, Aurore, et al.
Publicado: (2021) -
Glioblastoma-Specific Strategies of Vascularization: Implications in Anti-Angiogenic Therapy Resistance
por: Buccarelli, Mariachiara, et al.
Publicado: (2022)